Industry News
Bone Therapeutics invests in cell therapy manufacturing facility
Bone Therapeutics, an international biopharmaceutical company focused on innovative cell therapy products for the treatment of bone diseases, has announced that it has secured its future manufacturing requirements, allowing it to produce its bone cell therapy products on a commercial scale. [ + ]
Models made for science at University of Sydney exhibition
An exhibition at the University of Sydney’s Macleay Museum provides a rare opportunity to see models used to teach science and medicine at the university from the 1880s. [ + ]
New workforce development service will help SMEs improve their competitive edge
A Manufacturing Workforce Development Service (MWDS) has been formed to specifically work with manufacturing SMEs to support and help them access the Australian government’s National Workforce Development Fund (NWDF). [ + ]
NSW Government funding for researchers competing for Commonwealth grants
Deputy Premier and Minister for Trade & Investment Andrew Stoner is urging NSW’s leading research centres to tap into state government funding offering them a more competitive edge in attracting lucrative Commonwealth grants. [ + ]
AtCor signs $800K contract expansion
AtCor Medical (ASX:ACG) has expanded an existing contract to supply its SphygmoCor diagnostic to the tune of $800,000. [ + ]
AtCor swings to profit
AtCor Medical (ASX:ACG) has reported its second ever half-year profit for 1H13 thanks to revenue growth and cost-cutting. [ + ]
New imaging device is flexible, flat and transparent
An Austrian research team has developed an entirely new way of capturing images based on a flat, flexible, transparent and potentially disposable polymer sheet. [ + ]
Birth order linked to increased risk of diabetes, metabolic disorders
Long a source of sibling rivalry, birth order may raise the risk of first-born children developing diabetes or high blood pressure. [ + ]
Movers & shakers: Another Farrell to head ResMed
Mick Farrell, son of Dr Peter Farrell, will take over as CEO of ResMed while his father transitions to non-executive chairman. [ + ]
PolyActiva $9.2m cash injection
PolyActiva has raised $9.2m to further the development of its polymer drug delivery technology platform. [ + ]
Phosphagenics working on topical opioid patch
Phosphagenics (ASX:POH) will bring a new product to trials after preclinical research showed oxycodone delivered with its TPM tech can provide pain relief without entering the blood. [ + ]
Neurotrauma research to benefit from development grants
Twelve new research projects focusing on improving outcomes for Transport Accident Commission (TAC) and WorkSafe Victoria clients have been funded through the Institute for Safety, Compensation and Recovery Research (ISCRR) 2013 Development Grants Program. [ + ]
UWA becomes a global online classroom
The first free online courses in arts and science are about to be offered at The University of Western Australia in collaboration with US internet-study pioneer Stanford University. [ + ]
Industry applauds Labor policy to aid innovation
Labor announced yesterday its long-awaited policy on jobs and innovation, offering several reforms aimed at aiding innovative companies and biotechs. [ + ]
Gene patent upheld by Federal Court
The Federal Court has ruled in favour of Myriad Genetics and its patent of mutations in the BRCA1 gene, although some have expressed concern at the result. [ + ]
